Log in to save to my catalogue

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric ca...

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1999867429

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

About this item

Full title

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

Publisher

Tokyo: Springer Japan

Journal title

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2018-09, Vol.21 (5), p.819-830

Language

English

Formats

Publication information

Publisher

Tokyo: Springer Japan

More information

Scope and Contents

Contents

Background
Ramucirumab improves survival in gastric cancer patients. The efficacy and safety of ramucirumab outside of a clinical trial were evaluated using an expanded access program (EAP).
Methods
Advanced gastric cancer patients treated with ramucirumab in combination with paclitaxel or with ramucirumab monotherapy in a Korean EAP were...

Alternative Titles

Full title

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1999867429

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1999867429

Other Identifiers

ISSN

1436-3291

E-ISSN

1436-3305

DOI

10.1007/s10120-018-0806-1

How to access this item